[1]
Suttichaimongkol, T., Mitpracha, M., Tangvoraphonkchai, K., Sadeea, P., Sawanyawisuth, K. and Sukeepaisarnjaroen, W. 2023. PIVKA-II or AFP has better diagnostic properties for hepatocellular carcinoma diagnosis in high-risk patients. Journal of Circulating Biomarkers. 12, 1 (Feb. 2023), 12–16. DOI:https://doi.org/10.33393/jcb.2023.2453.